Pharmacology Clear and Simple 4th Edition TEST BANK
by Watkins, All Chapters 1 - 21 EXAM with Questions and
Answers/Plus a Rationale Updated 2026 A+/Instant
Download PDF
EXAM COVERAGE - 1. History of Pharmacology and Safe
Medication Administration - 2. Basic Principles of Pharmacology,
Drug Legislation, and Ethics - 3. Mathematical Calculations and
Medication Measurement - 4. Medication Administration Routes and
Safety Procedures - 5. Nutrition, Vitamins, Minerals, and Fluid
Balance - 6. Dermatologic and Topically Applied Agents - 7.
Musculoskeletal System Medications - 8. Nervous System and Mental
Health Medications - 9. Sensory System Medications (Eye and Ear) -
10. Endocrine System Medications - 11. Cardiovascular System
Medications - 12. Respiratory System Medications - 13.
Gastrointestinal System Medications - 14. Reproductive and Urinary
System Medications - 15. Anti-infective and Antimicrobial Agents - 16.
Cancer Therapies and Immunomodulators - 17. Analgesic, Anti-
inflammatory, and Antipyretic Agents - 18. Anesthetic Agents and
Sedatives - 19. Vaccines, Immunizations, and Biological Response
Modifiers - 20. Emergency Preparedness, Toxicology, and Antidotes -
21. Pediatric and Geriatric Pharmacology Considerations
1. A patient with severe rheumatoid arthritis is prescribed a biological response modifier. Prior to
initiating therapy, the nurse performs baseline screening. Which baseline diagnostic assessment
is the highest priority before initiating this therapeutic regimen?
A. Serum creatinine and blood urea nitrogen levels
B. Tuberculin skin test (PPD) or Interferon-Gamma Release Assay (IGRA)
C. Baseline chest X-ray for pulmonary fibrosis
D. Serum potassium and electrocardiogram (ECG)
Answer: B
Rationale: Biological response modifiers, particularly TNF-alpha inhibitors, significantly impair
cell-mediated immunity and can cause the reactivation of latent tuberculosis (TB). Performing a
, baseline Tuberculin skin test or IGRA is imperative before therapy to prevent life-threatening
disseminated TB. While renal function and baseline chest imaging may be relevant in broad
assessment, ruling out latent TB is the absolute clinical priority. Options A, C, and D do not
target the primary black-box infectious risk associated with immunosuppressive biologics.
2. A patient in the intensive care unit is receiving continuous intravenous furosemide for acute
decompensated heart failure. The nurse notes new-onset telemetry changes including flattened T
waves and prominent U waves. Which intervention should the nurse anticipate executing
immediately?
A. Administering rapid intravenous sodium chloride 0.9%
B. Preparing intravenous calcium gluconate pushing over 2 minutes
C. Administering intravenous potassium chloride infusion via volumetric pump
D. Discontinuing furosemide and starting spironolactone orally
Answer: C
Rationale: Loop diuretics such as furosemide promote marked renal excretion of potassium,
leading to severe hypokalemia, which is classic for flattened T waves and emerging U waves on
an ECG. Prompt IV replacement of potassium chloride using a regulated infusion pump is
critical to prevent fatal ventricular dysrhythmias. Sodium chloride (A) does not rectify potassium
deficits. Calcium gluconate (B) is used to stabilize cardiac membranes in hyperkalemia, not
hypokalemia. Oral spironolactone (D) acts too slowly in an acute symptomatic setting.
3. An elderly patient receiving digoxin 0.125 mg daily presents with anorexia, blurred vision with
yellow halos, and a heart rate of 48 beats/min. Serum digoxin level returns at 2.8 ng/mL. Which
agent should be available for emergency reversal?
A. Protamine sulfate
B. Digoxin immune Fab (Digibind)
C. Phytonadione (Vitamin K)
D. Idarucizumab
Answer: B
Rationale: Serum digoxin levels above 2.0 ng/mL combined with classic neuro-visual and
cardiovascular toxicity (bradycardia, yellow-green halos, anorexia) indicate acute digoxin
toxicity. Digoxin immune Fab binds circulating free digoxin molecules, rendering them inactive
and allowing renal clearance. Protamine sulfate (A) is the antidote for heparin. Phytonadione
(C) reverses warfarin. Idarucizumab (D) is a specific reversal agent for dabigatran.
,4. A patient diagnosed with major depressive disorder is transitioned from a Monoamine Oxidase
Inhibitor (MAOI) to a Selective Serotonin Reuptake Inhibitor (SSRI). To prevent Serotonin
Syndrome, what length of washout period must be observed between discontinuing the MAOI
and initiating the SSRI?
A. 24 to 48 hours
B. 5 to 7 days
C. At least 14 days
D. 30 days
Answer: C
Rationale: MAOIs irreversibly inhibit the enzyme responsible for breaking down monoamines;
synthesis of new enzymes takes approximately two weeks. Administering an SSRI before a
mandatory 14-day washout period leads to massive accumulation of synaptic serotonin, causing
life-threatening Serotonin Syndrome. Short windows such as 24-48 hours or 5-7 days (A, B)
leave patient tissues vulnerable to hyperthermia, rigidity, and autonomic instability. A 30-day
window (D) is unnecessarily prolonged and leaves depression untreated.
5. A healthcare provider orders an intravenous vancomycin infusion. Thirty minutes after the
infusion starts, the patient develops flushing of the neck, face, and upper torso, accompanied by
mild pruritus and a drop in blood pressure. What is the nurse's immediate priority action?
A. Stop the infusion completely and administer sub-Q epinephrine
B. Slow the infusion rate of vancomycin and assess vital signs
C. Document the allergy in the medical record and switch to daptomycin
D. Administer IV push diphenhydramine and double the infusion rate
Answer: B
Rationale: The patient is experiencing Vancomycin Infusion Reaction (formerly Red Man
Syndrome), an IgE-independent histamine release triggered by rapid IV infusion. The immediate
intervention is to slow down the infusion rate (typically over 60–120 minutes) and monitor vital
signs; antihistamines may also be co-administered. Epinephrine (A) is reserved for true IgE-
mediated anaphylaxis (bronchospasm, angioedema). Stopping therapy permanently or switching
drugs (C) is unnecessary for infusion rate-related reactions. Doubling the rate (D) would
exacerbate the histamine surge.
, 6. A patient taking warfarin for chronic atrial fibrillation presents with an International Normalized
Ratio (INR) of 7.5 with no signs of active bleeding. According to standard clinical guidelines,
which action is most appropriate?
A. Administer 10 mg of Vitamin K via rapid IV push immediately
B. Withhold 1 to 2 doses of warfarin, monitor INR, and adjust dosage
C. Administer 2 units of fresh frozen plasma (FFP) immediately
D. Administer protamine sulfate IV over 10 minutes
Answer: B
Rationale: For an elevated INR between 4.5 and 10.0 without significant active bleeding,
consensus guidelines recommend withholding 1 or 2 doses of warfarin, monitoring INR closely,
and resuming at an adjusted lower dose once within target range. Routine high-dose IV Vitamin
K (A) is avoided due to the risk of anaphylaxis and prolonged warfarin resistance. Fresh frozen
plasma (C) is reserved for emergency major bleeding. Protamine sulfate (D) reverses heparin,
not warfarin.
7. A client with asthmatic bronchitis is prescribed an inhaled corticosteroid (fluticasone) and a
short-acting beta-2 agonist (albuterol) metered-dose inhaler (MDI). Which instruction must the
nurse emphasize regarding administration sequence?
A. Administer albuterol first, wait 5 minutes, then administer fluticasone
B. Administer fluticasone first, wait 5 minutes, then administer albuterol
C. Mix both medications together inside the spacer before inhaling
D. Use fluticasone strictly as needed for acute bronchospasm episodes
Answer: A
Rationale: Albuterol is a rapid-acting bronchodilator that relaxes airway smooth muscle,
opening bronchial passages. Administering albuterol 5 minutes prior to fluticasone allows the
inhaled corticosteroid to penetrate deeper into the distal lung tissue for optimal anti-
inflammatory effect. Inhaled corticosteroids have no acute bronchodilatory properties (D) and
should not precede the bronchodilator (B). MDIs are not combined directly inside spacers (C).
8. A patient receiving heparin sodium via continuous IV infusion has an activated Partial
Thromboplastin Time (aPTT) of 115 seconds (control/baseline is 30 seconds). The patient
displays petechiae and hematuria. Which agent should be administered immediately?
A. Vitamin K1 (Phytonadione)
by Watkins, All Chapters 1 - 21 EXAM with Questions and
Answers/Plus a Rationale Updated 2026 A+/Instant
Download PDF
EXAM COVERAGE - 1. History of Pharmacology and Safe
Medication Administration - 2. Basic Principles of Pharmacology,
Drug Legislation, and Ethics - 3. Mathematical Calculations and
Medication Measurement - 4. Medication Administration Routes and
Safety Procedures - 5. Nutrition, Vitamins, Minerals, and Fluid
Balance - 6. Dermatologic and Topically Applied Agents - 7.
Musculoskeletal System Medications - 8. Nervous System and Mental
Health Medications - 9. Sensory System Medications (Eye and Ear) -
10. Endocrine System Medications - 11. Cardiovascular System
Medications - 12. Respiratory System Medications - 13.
Gastrointestinal System Medications - 14. Reproductive and Urinary
System Medications - 15. Anti-infective and Antimicrobial Agents - 16.
Cancer Therapies and Immunomodulators - 17. Analgesic, Anti-
inflammatory, and Antipyretic Agents - 18. Anesthetic Agents and
Sedatives - 19. Vaccines, Immunizations, and Biological Response
Modifiers - 20. Emergency Preparedness, Toxicology, and Antidotes -
21. Pediatric and Geriatric Pharmacology Considerations
1. A patient with severe rheumatoid arthritis is prescribed a biological response modifier. Prior to
initiating therapy, the nurse performs baseline screening. Which baseline diagnostic assessment
is the highest priority before initiating this therapeutic regimen?
A. Serum creatinine and blood urea nitrogen levels
B. Tuberculin skin test (PPD) or Interferon-Gamma Release Assay (IGRA)
C. Baseline chest X-ray for pulmonary fibrosis
D. Serum potassium and electrocardiogram (ECG)
Answer: B
Rationale: Biological response modifiers, particularly TNF-alpha inhibitors, significantly impair
cell-mediated immunity and can cause the reactivation of latent tuberculosis (TB). Performing a
, baseline Tuberculin skin test or IGRA is imperative before therapy to prevent life-threatening
disseminated TB. While renal function and baseline chest imaging may be relevant in broad
assessment, ruling out latent TB is the absolute clinical priority. Options A, C, and D do not
target the primary black-box infectious risk associated with immunosuppressive biologics.
2. A patient in the intensive care unit is receiving continuous intravenous furosemide for acute
decompensated heart failure. The nurse notes new-onset telemetry changes including flattened T
waves and prominent U waves. Which intervention should the nurse anticipate executing
immediately?
A. Administering rapid intravenous sodium chloride 0.9%
B. Preparing intravenous calcium gluconate pushing over 2 minutes
C. Administering intravenous potassium chloride infusion via volumetric pump
D. Discontinuing furosemide and starting spironolactone orally
Answer: C
Rationale: Loop diuretics such as furosemide promote marked renal excretion of potassium,
leading to severe hypokalemia, which is classic for flattened T waves and emerging U waves on
an ECG. Prompt IV replacement of potassium chloride using a regulated infusion pump is
critical to prevent fatal ventricular dysrhythmias. Sodium chloride (A) does not rectify potassium
deficits. Calcium gluconate (B) is used to stabilize cardiac membranes in hyperkalemia, not
hypokalemia. Oral spironolactone (D) acts too slowly in an acute symptomatic setting.
3. An elderly patient receiving digoxin 0.125 mg daily presents with anorexia, blurred vision with
yellow halos, and a heart rate of 48 beats/min. Serum digoxin level returns at 2.8 ng/mL. Which
agent should be available for emergency reversal?
A. Protamine sulfate
B. Digoxin immune Fab (Digibind)
C. Phytonadione (Vitamin K)
D. Idarucizumab
Answer: B
Rationale: Serum digoxin levels above 2.0 ng/mL combined with classic neuro-visual and
cardiovascular toxicity (bradycardia, yellow-green halos, anorexia) indicate acute digoxin
toxicity. Digoxin immune Fab binds circulating free digoxin molecules, rendering them inactive
and allowing renal clearance. Protamine sulfate (A) is the antidote for heparin. Phytonadione
(C) reverses warfarin. Idarucizumab (D) is a specific reversal agent for dabigatran.
,4. A patient diagnosed with major depressive disorder is transitioned from a Monoamine Oxidase
Inhibitor (MAOI) to a Selective Serotonin Reuptake Inhibitor (SSRI). To prevent Serotonin
Syndrome, what length of washout period must be observed between discontinuing the MAOI
and initiating the SSRI?
A. 24 to 48 hours
B. 5 to 7 days
C. At least 14 days
D. 30 days
Answer: C
Rationale: MAOIs irreversibly inhibit the enzyme responsible for breaking down monoamines;
synthesis of new enzymes takes approximately two weeks. Administering an SSRI before a
mandatory 14-day washout period leads to massive accumulation of synaptic serotonin, causing
life-threatening Serotonin Syndrome. Short windows such as 24-48 hours or 5-7 days (A, B)
leave patient tissues vulnerable to hyperthermia, rigidity, and autonomic instability. A 30-day
window (D) is unnecessarily prolonged and leaves depression untreated.
5. A healthcare provider orders an intravenous vancomycin infusion. Thirty minutes after the
infusion starts, the patient develops flushing of the neck, face, and upper torso, accompanied by
mild pruritus and a drop in blood pressure. What is the nurse's immediate priority action?
A. Stop the infusion completely and administer sub-Q epinephrine
B. Slow the infusion rate of vancomycin and assess vital signs
C. Document the allergy in the medical record and switch to daptomycin
D. Administer IV push diphenhydramine and double the infusion rate
Answer: B
Rationale: The patient is experiencing Vancomycin Infusion Reaction (formerly Red Man
Syndrome), an IgE-independent histamine release triggered by rapid IV infusion. The immediate
intervention is to slow down the infusion rate (typically over 60–120 minutes) and monitor vital
signs; antihistamines may also be co-administered. Epinephrine (A) is reserved for true IgE-
mediated anaphylaxis (bronchospasm, angioedema). Stopping therapy permanently or switching
drugs (C) is unnecessary for infusion rate-related reactions. Doubling the rate (D) would
exacerbate the histamine surge.
, 6. A patient taking warfarin for chronic atrial fibrillation presents with an International Normalized
Ratio (INR) of 7.5 with no signs of active bleeding. According to standard clinical guidelines,
which action is most appropriate?
A. Administer 10 mg of Vitamin K via rapid IV push immediately
B. Withhold 1 to 2 doses of warfarin, monitor INR, and adjust dosage
C. Administer 2 units of fresh frozen plasma (FFP) immediately
D. Administer protamine sulfate IV over 10 minutes
Answer: B
Rationale: For an elevated INR between 4.5 and 10.0 without significant active bleeding,
consensus guidelines recommend withholding 1 or 2 doses of warfarin, monitoring INR closely,
and resuming at an adjusted lower dose once within target range. Routine high-dose IV Vitamin
K (A) is avoided due to the risk of anaphylaxis and prolonged warfarin resistance. Fresh frozen
plasma (C) is reserved for emergency major bleeding. Protamine sulfate (D) reverses heparin,
not warfarin.
7. A client with asthmatic bronchitis is prescribed an inhaled corticosteroid (fluticasone) and a
short-acting beta-2 agonist (albuterol) metered-dose inhaler (MDI). Which instruction must the
nurse emphasize regarding administration sequence?
A. Administer albuterol first, wait 5 minutes, then administer fluticasone
B. Administer fluticasone first, wait 5 minutes, then administer albuterol
C. Mix both medications together inside the spacer before inhaling
D. Use fluticasone strictly as needed for acute bronchospasm episodes
Answer: A
Rationale: Albuterol is a rapid-acting bronchodilator that relaxes airway smooth muscle,
opening bronchial passages. Administering albuterol 5 minutes prior to fluticasone allows the
inhaled corticosteroid to penetrate deeper into the distal lung tissue for optimal anti-
inflammatory effect. Inhaled corticosteroids have no acute bronchodilatory properties (D) and
should not precede the bronchodilator (B). MDIs are not combined directly inside spacers (C).
8. A patient receiving heparin sodium via continuous IV infusion has an activated Partial
Thromboplastin Time (aPTT) of 115 seconds (control/baseline is 30 seconds). The patient
displays petechiae and hematuria. Which agent should be administered immediately?
A. Vitamin K1 (Phytonadione)
